Pluviaendo Visuals Pluviaendo Visuals

X

CAS 35303-76-5 manufacturers and suppliers on PharmaCompass

PharmaCompass
CAS 35303-76-5
Also known as: 35303-76-5, 4-(2-aminoethyl)benzene-1-sulfonamide, Benzenesulfonamide, 4-(2-aminoethyl)-, 4-(2-aminoethyl)benzene sulfonamide, 4-(2-aminoethyl)benzenesulphonamide, 4-(2-amino-ethyl)-benzenesulfonamide
Molecular Formula
C8H12N2O2S
Molecular Weight
200.26  g/mol
InChI Key
FXNSVEQMUYPYJS-UHFFFAOYSA-N
FDA UNII
WIA59Y34CJ

1 2D Structure

CAS 35303-76-5

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
4-(2-aminoethyl)benzenesulfonamide
2.1.2 InChI
InChI=1S/C8H12N2O2S/c9-6-5-7-1-3-8(4-2-7)13(10,11)12/h1-4H,5-6,9H2,(H2,10,11,12)
2.1.3 InChI Key
FXNSVEQMUYPYJS-UHFFFAOYSA-N
2.1.4 Canonical SMILES
C1=CC(=CC=C1CCN)S(=O)(=O)N
2.2 Other Identifiers
2.2.1 UNII
WIA59Y34CJ
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Aebsnh2

2.3.2 Depositor-Supplied Synonyms

1. 35303-76-5

2. 4-(2-aminoethyl)benzene-1-sulfonamide

3. Benzenesulfonamide, 4-(2-aminoethyl)-

4. 4-(2-aminoethyl)benzene Sulfonamide

5. 4-(2-aminoethyl)benzenesulphonamide

6. 4-(2-amino-ethyl)-benzenesulfonamide

7. Mfcd00010301

8. Chembl7087

9. Wia59y34cj

10. 4-aminoethylbenzenesulfonamide

11. 2-(4-sulfamoylphenyl)ethylamine

12. 4-(2-aminoethyl)benzesulfonamide

13. 4-(2-aminoethyl)-benzenesulfonamide Hydrochloride

14. Einecs 252-501-0

15. 4-(2-aminoethyl) Benzenesulfonamide

16. 4-(2-aminoethyl)benzene-sulfonamide

17. Aebs

18. 4-(2-aminoethyl)benzene Sulphonamide

19. Unii-wia59y34cj

20. Ec 252-501-0

21. Timtec1_004114

22. Oprea1_683536

23. Cbdive_002752

24. Mls000776589

25. Schembl142107

26. Aromatic Sulfonamide Compound 7

27. Bdbm10861

28. Zinc56629

29. Dtxsid20188814

30. Hms1545k22

31. Hms2682a23

32. Hms3604d10

33. P-(2-aminoethyl)benzenesulfonamide

34. Bcp13828

35. Str01507

36. 2-(4-sulfamoyl-phenyl)-ethyl-amine

37. 4-(2-amino-ethyl)benzenesulfonamide

38. 4--(2-aminoethyl)benzenesulfonamide

39. Aromatic/heteroaromatic Sulfonamide 6

40. Bbl018125

41. Stl102633

42. 4-(2-amino Ethyl)benzene Sulfonamide

43. P-aminoethyl Benzenesulfonamide

44. 4-(beta-aminoethyl)-benzenesulfonamide

45. Akos000119356

46. P-(beta-aminoethyl)-benzenesulfonamide

47. 2-[4-(aminosulfonyl)phenyl]ethylamine

48. Db08782

49. Sb78461

50. 2-amino Ethyl Benzene Sulfonamide

51. Ncgc00245988-01

52. Para-(beta-aminoethyl)benzenesulphonamide

53. Ac-18741

54. Bp-20147

55. Smr000371838

56. 4-(2-aminoethyl)benzenesulfonamide, 99%

57. Db-048777

58. Am20040264

59. Bb 0218502

60. Ft-0616511

61. D70143

62. A822722

63. W-106677

64. Q27097962

65. Z56755653

66. F0051-0002

67. Zyx

2.4 Create Date
2005-03-26
3 Chemical and Physical Properties
Molecular Weight 200.26 g/mol
Molecular Formula C8H12N2O2S
XLogP3-0.2
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count4
Rotatable Bond Count3
Exact Mass200.06194880 g/mol
Monoisotopic Mass200.06194880 g/mol
Topological Polar Surface Area94.6 Ų
Heavy Atom Count13
Formal Charge0
Complexity237
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Flag China
Digital Content Digital Content
URL Supplier Web Content
32175-00-1
Glimepiride
Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary locat...
Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary located in National Cangzhou Lingang Economic and Technological Development Zone,Cangzhou City,Hebei Province. Senary cover an area of 67,000 square meters, and 300 professionals work there. Senary R&D organization recognized as the Hebei Provincial Engineering Technology Center is comprised of two R & D centers in Tianjin and Cangzhou, and it employs 80 experienced scientists in total. Senary focus on the development, production and sales of advanced pharmaceutical intermediates. Especially, Senary has leading technology and manufacturing capacity for diabetes drug intermediates. All intermediates of DPP4 and SGLT2 class drugs on market have been commercialized production. Senary has 150 sets of 50 ~ 8000L reactor with annual production capacity of 1,000 tons, which can handle both low and high temperature reactions within -100 ~ 240 ℃ range, all kinds of catalytic reactions within 0 ~ 5MPa pressure, and moisture and/or oxygen sensitive reactions. Senary also has expertise in chiral synthesis with leading technologies. The advanced sewage treatment system at Senery has processing capacity of 600 tons daily. Senary has an excellent team that has rich quality management experience.We have established a set of normative and perfect quality managment system,monitoring the whole process of risk assessment,R&D,transfer from pilot scale to commercial production,manufacturing,analysis and sales service. Senary will continue to dedicate on the field of pharmaceutical intermediates to provide the best service for domestic and foreign API pharmaceutical companies with high quality and timely supply of products.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag China
Digital Content Digital Content
URL Supplier Web Content
766-36-9
Glimepiride
Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary locat...
Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary located in National Cangzhou Lingang Economic and Technological Development Zone,Cangzhou City,Hebei Province. Senary cover an area of 67,000 square meters, and 300 professionals work there. Senary R&D organization recognized as the Hebei Provincial Engineering Technology Center is comprised of two R & D centers in Tianjin and Cangzhou, and it employs 80 experienced scientists in total. Senary focus on the development, production and sales of advanced pharmaceutical intermediates. Especially, Senary has leading technology and manufacturing capacity for diabetes drug intermediates. All intermediates of DPP4 and SGLT2 class drugs on market have been commercialized production. Senary has 150 sets of 50 ~ 8000L reactor with annual production capacity of 1,000 tons, which can handle both low and high temperature reactions within -100 ~ 240 ℃ range, all kinds of catalytic reactions within 0 ~ 5MPa pressure, and moisture and/or oxygen sensitive reactions. Senary also has expertise in chiral synthesis with leading technologies. The advanced sewage treatment system at Senery has processing capacity of 600 tons daily. Senary has an excellent team that has rich quality management experience.We have established a set of normative and perfect quality managment system,monitoring the whole process of risk assessment,R&D,transfer from pilot scale to commercial production,manufacturing,analysis and sales service. Senary will continue to dedicate on the field of pharmaceutical intermediates to provide the best service for domestic and foreign API pharmaceutical companies with high quality and timely supply of products.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag China
Digital Content Digital Content
URL Supplier Web Content
2523-55-9
Glimepiride
Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary locat...
Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary located in National Cangzhou Lingang Economic and Technological Development Zone,Cangzhou City,Hebei Province. Senary cover an area of 67,000 square meters, and 300 professionals work there. Senary R&D organization recognized as the Hebei Provincial Engineering Technology Center is comprised of two R & D centers in Tianjin and Cangzhou, and it employs 80 experienced scientists in total. Senary focus on the development, production and sales of advanced pharmaceutical intermediates. Especially, Senary has leading technology and manufacturing capacity for diabetes drug intermediates. All intermediates of DPP4 and SGLT2 class drugs on market have been commercialized production. Senary has 150 sets of 50 ~ 8000L reactor with annual production capacity of 1,000 tons, which can handle both low and high temperature reactions within -100 ~ 240 ℃ range, all kinds of catalytic reactions within 0 ~ 5MPa pressure, and moisture and/or oxygen sensitive reactions. Senary also has expertise in chiral synthesis with leading technologies. The advanced sewage treatment system at Senery has processing capacity of 600 tons daily. Senary has an excellent team that has rich quality management experience.We have established a set of normative and perfect quality managment system,monitoring the whole process of risk assessment,R&D,transfer from pilot scale to commercial production,manufacturing,analysis and sales service. Senary will continue to dedicate on the field of pharmaceutical intermediates to provide the best service for domestic and foreign API pharmaceutical companies with high quality and timely supply of products.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag China
Digital Content Digital Content
URL Supplier Web Content
119018-29-0
Glimepiride
Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary locat...
Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary located in National Cangzhou Lingang Economic and Technological Development Zone,Cangzhou City,Hebei Province. Senary cover an area of 67,000 square meters, and 300 professionals work there. Senary R&D organization recognized as the Hebei Provincial Engineering Technology Center is comprised of two R & D centers in Tianjin and Cangzhou, and it employs 80 experienced scientists in total. Senary focus on the development, production and sales of advanced pharmaceutical intermediates. Especially, Senary has leading technology and manufacturing capacity for diabetes drug intermediates. All intermediates of DPP4 and SGLT2 class drugs on market have been commercialized production. Senary has 150 sets of 50 ~ 8000L reactor with annual production capacity of 1,000 tons, which can handle both low and high temperature reactions within -100 ~ 240 ℃ range, all kinds of catalytic reactions within 0 ~ 5MPa pressure, and moisture and/or oxygen sensitive reactions. Senary also has expertise in chiral synthesis with leading technologies. The advanced sewage treatment system at Senery has processing capacity of 600 tons daily. Senary has an excellent team that has rich quality management experience.We have established a set of normative and perfect quality managment system,monitoring the whole process of risk assessment,R&D,transfer from pilot scale to commercial production,manufacturing,analysis and sales service. Senary will continue to dedicate on the field of pharmaceutical intermediates to provide the best service for domestic and foreign API pharmaceutical companies with high quality and timely supply of products.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY